This agreement between Alcon subsidiary of Novartis, and megabuscador Internet could revolutionize eye care, said the Swiss group through a statement.
This is because it will combine the technological advances of Google, miniaturization of electronics, with experience in the pharmaceutical field Novartis and medical devices.
"We look forward to working with Google to combine advanced technology and our extensive knowledge in biology, and to serve unmet medical needs," said Joseph Jimenez, CEO of Novartis, said in the press release.
Jimenez stressed that this agreement is an important step in understanding the disease beyond the limits of traditional medicine.
"Our dream is to use the latest technology miniaturization of electronics, to help improve the lives of millions of people," said for his part Sergey Brin, co-founder of Google, in a statement.
Currently Novartis interest in this technology focuses on two segments, the group said.
NOVARTIS PUTS FOCUS ON PATIENTS WITH DIABETES AND PRESBYOPIA
First, it may help diabetic patients control their disease, allowing them to continuously measure glucose levels through a lens Intelligent Touch, designed to measure the level of tear fluid in the eye and connected to a medical device with a wireless connection .
While the second would use for people suffering from presbyopia, and therefore can not be read without his glasses placed.
0 comments:
Post a Comment